Neuroendocrine phenotype, chemosensitivity and prognosis in adenocarcinoma of the lung.
Souhami
R L
RL
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D004351:Drug Resistance; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D010641:Phenotype; D010751:Phosphopyruvate Hydratase / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D010751:Phosphopyruvate Hydratase